Arrotex Formed As Strides-Apotex Merger Completes In Australia
Arrotex Australia Group has been formed in Australia following the completion of the merger between Strides’ Arrow and Apotex’ local unit.
You may also be interested in...
Arun Kumar is stepping down as chief executive of Strides Pharma to focus on overall corporate strategy and the company’s return to injectables. He will be replaced by former Cipla chief operating officer R Ananthanarayanan.
Scrip highlights the key transactions involving Indian firms in 2019. Divestments and licensing were among the prominent themes that dotted the deal landscape in the year gone by.
Court grants request to substitute Accord BioPharma for Apotex in Amgen infringement suit. Apotex says it has no plans to exit the biosimilar business.